Helma Freitag
From MEpedia, a crowd-sourced encyclopedia of ME and CFS science and history
Ms. Helma Freitag, researches at the Institute for Medical Immunology, Charité Universitätsmedizin Berlin, Germany.
EUROMENE[edit | edit source]
Ms. Freitag is a substitute member of the Biomarkers Working Group of ME/CFS across Europe on behalf of EUROMENE, a European Union COST Action CA15111 not-for-profit research organization committed to tackling the cause and treatment for Myalgic Encephalomyelitis/Chronic Fatigue Syndrome.[1]
Notable studies[edit | edit source]
- 2017, The European ME/CFS Biomarker Landscape project: an initiative of the European network EUROMENE[2] (Full Text)
- 2018, Immunoadsorption to remove ß2 adrenergic receptor antibodies in Chronic Fatigue Syndrome CFS/ME[3] (Full Text)
Talks and interviews[edit | edit source]
Online presence[edit | edit source]
- PubMed
- ResearchGate
Learn more[edit | edit source]
See also[edit | edit source]
References[edit | edit source]
- ↑ http://www.cost.eu/COST_Actions/ca/CA15111?management
- ↑ Scheibenbogen, Carmen; Freitag, Helma; Blanco, Julià; Capelli, Enrica; Lacerda, Eliana; Authier, Jerome; Meeus, Mira; Castro Marrero, Jesus; Nora-Krukle, Zaiga; Oltra, Elisa; Bolle Strand, Elin; Shikova, Evelina; Sekulic, Slobodan; Murovska, Modra (2017), "The European ME/CFS Biomarker Landscape project: an initiative of the European network EUROMENE", Journal of Translational Medicine, 15: 162, doi:10.1186/s12967-017-1263-z
- ↑ Scheibenbogen, Carmen; Loebel, Madlen; Freitag, Helma; Krueger, Anne; Bauer, Sandra; Antelmann, Michaela; Doehner, Wolfram; Scherbakov, Nadja; Heidecke, Harald; Reinke, Petra; Volk, Hans-Dieter; Grabowski, Patricia (2018). "Immunoadsorption to remove ß2 adrenergic receptor antibodies in Chronic Fatigue Syndrome CFS/ME". PLoS ONE. 13 (3): e0193672. doi:10.1371/journal.pone.0193672.
